Novel Chemotherapy Agent Bendamustine Significantly More Effective First-Line Therapy Than Chlorambucil in CLL
Blood Marrow Normalised in 31% (Versus 2%) of Patients, With Manageable Side-Effects
06-Aug-2009 -
Nearly a third (31%) of all bendamustine-treated patients saw all clinical evidence of their advanced chronic lymphocytic leukaemia (CLL) disappear when used as a first-line treatment option, according to the results of a large new multicentre phase III study published by the Journal of Clinical ...
chemotherapy
oncology
toxicity